Understand the source comparison
Best Peptides for Carpal Tunnel: Research Comparison
BPC-157 Collagen synthesis acceleration via FGF/VEGF pathways 200–500 mcg daily (animal models) 4–6 hours Angiogenesis, nitric oxide production Most studied for tendon repair; partial oral bioavailability in rats; best-documented safety profile in preclinical
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Collagen synthesis acceleration via FGF/VEGF pathways
- 200–500 mcg daily (animal models)
- 4–6 hours
- Angiogenesis, nitric oxide production
- Most studied for tendon repair; partial oral bioavailability in rats; best-documented safety profile in preclinical models
- TB-500
- Cell migration and angiogenesis through actin regulation
- 2–5 mg twice weekly (animal models)
- Several days
- VEGF upregulation, endothelial cell proliferation
- Strongest evidence for nerve regeneration; longer half-life supports less frequent dosing; limited human pharmacokinetic data
- GHK-Cu
- MMP activation for collagen remodeling
- 1–3 mg daily (animal models)
- Poorly characterized
- Matrix metalloproteinase pathways, copper-dependent enzymes
- Dual action on collagen breakdown and synthesis; minimal bioavailability data; transdermal formulations unverified
- Dihexa
- Hepatocyte growth factor (HGF) potentiation for nerve growth
- 5–10 mg/kg in rodent models
- Unknown in humans
- HGF/Met receptor pathway
- Primarily cognitive research; potential for peripheral nerve applications unexplored
- Cerebrolysin
- Neuroprotective peptide mixture derived from porcine brain
- 10–60 mL IV in clinical trials
- Multiple components
- BDNF, NGF pathways
- Used clinically in some countries for stroke recovery; peripheral nerve data minimal; IV-only administration